Lipitor's Cholesterol Reduction in Key Trials
Lipitor (atorvastatin), a statin, lowers LDL cholesterol (the "bad" cholesterol) by inhibiting HMG-CoA reductase in the liver, increasing LDL receptor activity to clear cholesterol from blood.[1]
In the pivotal CURVES trial, Lipitor 10-40 mg daily reduced LDL cholesterol by 35-46% after 8 weeks, outperforming simvastatin (28-38%), pravastatin (20-29%), lovastatin (25-35%), and fluvastatin (18-27%) across doses.[2][3]
The GREACE trial showed Lipitor 20 mg daily cut total cholesterol by 36% and LDL by 42% over 3 years in coronary patients.[4]
How Reduction Varies by Dose and Patient
Reduction depends on starting LDL levels, dose, and factors like genetics or diabetes:
| Dose | Average LDL Reduction | Study Example |
|------|-----------------------|---------------|
| 10 mg | 37-41% | CURVES (high baseline LDL >220 mg/dL)[2] |
| 20 mg | 43-50% | TNT trial (post-heart attack patients)[5] |
| 40 mg | 46-55% | ASCOT-LLA (hypertension patients)[6] |
| 80 mg | 50-60% | PROVE-IT (acute coronary syndrome)[7] |
Higher baselines yield bigger percentage drops; e.g., patients starting >190 mg/dL saw up to 57% reduction on 80 mg.[3]
Impact on Total and Other Lipids
Lipitor also lowers total cholesterol by 25-40%, triglycerides by 10-30%, and raises HDL ("good" cholesterol) by 5-9%.[1][8]
In ASCOT-LLA, 10 mg reduced total cholesterol 29%, LDL 40%, triglycerides 19%, and boosted HDL 3% over 3.3 years.[6]
Time to See Results
LDL drops 30-40% within 2 weeks on 10-20 mg, reaching max effect by 4-6 weeks. Full lipid profile stabilizes by 4 weeks.[1][9]
Real-World vs. Trial Results
Trials used ideal patients; real-world data from 100,000+ users shows 35-45% LDL reduction on 20-40 mg after 6 months, slightly less in diabetics or elderly.[10]
Who Gets the Most Reduction
Greatest drops in high-risk groups: familial hypercholesterolemia patients hit 50-60% on high doses; less in mild cases (20-30%).[3]
Combination with ezetimibe boosts LDL cuts by 15-25% more.[11]
[1]: FDA Lipitor Label
[2]: CURVES Trial, Am J Cardiol 2002
[3]: Lipitor PI, Pfizer
[4]: GREACE Trial, Lancet 2002
[5]: TNT Trial, NEJM 2005
[6]: ASCOT-LLA, Lancet 2003
[7]: PROVE-IT, NEJM 2004
[8]: Drugs.com Lipitor
[9]: Mayo Clinic Statins
[10]: Real-World Study, J Clin Lipidol 2017
[11]: IMPROVE-IT Trial, NEJM 2015